Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

A Study to Learn How Different Tablets of the Study Medicine Vepdegestrant Are Taken up Into the Blood in Healthy Adults

← catalyst calendar

NCT06645938

Sponsored by Pfizer (industry) · PFE — their whole pipeline →. With Arvinas Estrogen Receptor, Inc..

Phase
Phase 1
Status
Completed
Study type
Interventional
Design
Randomized · None · Other
Enrollment
12actual
Sites
1
Country
Belgium

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Dates

each axis at the precision it was filed, with the registry's own basis
DateFiledBasisWhat it is
Start2024-10-16actualWhen the study began enrolling
Primary completion2025-02-20actualThe date the last participant is measured for the primary outcome — the readout window
Study completion2025-03-14actualThe whole study's end, after follow-up
First posted2024-10-17actualWhen this record first appeared on the registry
Results postedWhen the sponsor posted results to the registry
Record updated2025-05-25actualThe sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Condition

  • Healthy

Interventions

  • Drug: single dose of vepdegestrant as tablet formulation (Treatment A) — also filed as ARV-471, PF-07850327
  • Drug: single dose of vepdegestrant as tablet formulation (Treatment B) — also filed as ARV-471, PF-07850327

Primary outcomes

what the primary-completion date above is the date OF
Maximum Observed Plasma Concentration (Cmax) of Vepdegestrant
measured Period 1 and 2 - pre-dose, 1, 2, 4, 6, 8, 12, 24, 36, 48, 60, 72, 96, 120, 144, and 168 hour(s) post-dose
Area Under the Curve From Time Zero to Extrapolated Infinite Time (AUCinf) of Vepdegestrant
measured Period 1 and 2 - pre-dose, 1, 2, 4, 6, 8, 12, 24, 36, 48, 60, 72, 96, 120, 144, and 168 hour(s) post-dose

Permalink · PFE's whole pipeline · Catalyst calendar · Every registered study · What changed